Form 4: Primo Brands Corp Director Acquires Shares in Non-Derivative Transaction
SEC Form 4 Filing
Director C. Dean Metropoulos acquired 3,445 shares of Class A Common Stock in a non-derivative transaction.
Summary
- C. Dean Metropoulos, a director of Primo Brands Corp, acquired 3,445 shares of Class A Common Stock on November 8, 2024.
- The transaction was a non-derivative acquisition.
- The shares were acquired at a price of $0.
Sentiment
Score: 5
Explanation: The document is a routine filing and does not indicate any positive or negative sentiment. It is a neutral transaction.
Industry Context
This is a standard SEC Form 4 filing, which is common for corporate insiders reporting changes in their beneficial ownership of company stock. It is a routine disclosure and does not indicate any specific industry trend.
Comparison to Industry Standards
- Form 4 filings are a standard practice for publicly traded companies in the United States.
- The transaction is a typical example of a director acquiring shares, which is common across various industries.
- The $0 price per share suggests the shares were likely granted as part of a compensation package or other non-cash transaction, which is not unusual.
Stakeholder Impact
- The transaction increases the director's stake in the company, which could be viewed positively by shareholders.
Key Dates
| Date | Description |
|---|---|
| 11/08/2024 | Date of the share acquisition by C. Dean Metropoulos. |
| 11/13/2024 | Date of signature by Michael James, Attorney-in-Fact. |
Keywords
Form 4, Beneficial Ownership, Director, Share Acquisition, Non-Derivative, Primo Brands Corp, PRMB, Class A Common Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.